Aliskiren/amlodipine
In-game article clicks load inline without leaving the challenge.
The drug combination aliskiren/amlodipine (INNs, trade names Tekamlo and Rasilamlo) is an antihypertensive. Clinical trials have shown it to be more effective than amlodipine on its own, with a high dosing regime (aliskiren 300 mg/amlodipine 10 mg) being more effective than olmesartan/amlodipine with comparable tolerability.
Further reading
- . U.S. Food and Drug Administration. 19 January 2016. Archived from on September 23, 2019.
External links
- . Drug Information Portal. U.S. National Library of Medicine.[dead link]